Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 22, 2006
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical interventionArturo S Dela Pena, Walter Asperger, Ferdinand Köckerling, et al.
The Pediatric Infectious Disease Journal|June 29, 2006
Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United StatesSusan E Coffin, Joseph Elser, Colin Marchant, et al.
Surgical Infections|January 20, 2007
In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends)Grant V Bochicchio, Fernando Baquero, Po-Ren Hsueh, et al.
International Journal of Surgery (London, England)|April 28, 2007
Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infectionsNarcisco S Navarro, Maria I Campos, Ramon Alvarado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudinePaul M Coplan, John R Cook, George W Carides, et al.
Diagnostic Microbiology and Infectious Disease|May 19, 2007
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapyMark J DiNubile, Ian R Friedland, Christina Y Chan, et al.
Pediatrics|December 1, 2010
Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilizationCelia D C Christie, Newton D Duncan, Kirk A Thame, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infectionMartin S Hirsch, Roy T Steigbigel, Scholomo Staszewski, et al.
AIDS (London, England)|December 31, 2008
Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patientsEmmanouil Papasavvas, Maxwell Pistilli, Griffin Reynolds, et al.
Clinical and Vaccine Immunology : CVI|July 17, 2009
Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adultsClayton Harro, Xiao Sun, Jon E Stek, et al.
Pageof 10